<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=3198849&amp;fmt=gif">

Sign up now and receive the latest news about our ecosystem into your inbox!


On the 27th February 2024, Luxembourg Institute of Health (LIH) and Catalpa Ventures entered into a five-year collaborative agreement, marking a significant milestone in Luxembourg’s evolving HealthTech sector.

Catalpa is a Venture Capital Firm specialised in investing in early-stage technology companies revolutionising healthcare and recently opened its doors in Luxembourg. The collaboration seeks to capitalise on the synergy between scientific research and venture capital, particularly focusing on advancing digital health technologies.

Luxembourg’s commitment to fostering HealthTech innovation, supported by governmental initiatives and research institutions like the LIH, positions the country as a hub for translational e-health. Catalpa Ventures, recognising this potential, aims to play a pivotal role by establishing a venture capital fund specialising in HealthTech startups.

A bridge between the worlds of research and finance in Luxembourg

The agreement outlines a strategic framework for collaboration, encompassing various activities such as supporting LIH in hackathons, competitions, and the creation of spin-offs in Luxembourg. Catalpa Ventures, in return, aims to strengthen its venture capital activities by leveraging LIH’s scientific expertise, offering startups unique added value with specialised insights, guidance, and support from LIH’s scientific community, potentially setting them apart in the competitive landscape and encouraging innovation within the healthcare sector.

Prof Ulf Nehrbass, CEO of LIH, expressed enthusiasm about the collaboration, emphasising the potential for knowledge transfer and the application of Catalpa’s financial expertise to propel research into marketable healthcare solutions.

We believe that the numerous opportunities for knowledge transfer arising from this partnership and the availability of Catalpa’s financial and investment expertise to our researchers will create a bridge between research and its commercialisation. This will ensure that our scientific findings are marketable and can be translated into tangible healthcare solutions, easily accessible by clinicians and patients. Ulf Nehrbass, CEO of LIH

Dr Thomas Goergen, one of the Founding Partners of Catalpa, highlighted the collaborative effort to unlock the potential of digital health and translational research, ultimately contributing to improved healthcare and patient outcomes.

“When determining where to initiate our VC activities, choosing Luxembourg was a logical decision for us,” explained Dr Goergen. “Due to our positive experiences with Luxembourg as entrepreneurs ourselves we look forward to being the reliable partner for the dynamically growing ecosystem for HealthTech startups. This entails not only supporting ambitious Luxembourgish companies but also attracting HealthTech firms from Europe and beyond to utilize Luxembourg as their launchpad for international scaling.”

Both parties expressed their commitment to establishing a lasting strategic cooperation that bridges the worlds of research and finance in Luxembourg. The aim is to attract innovative e-health companies, unlocking the full potential of digital health and translational research. This collaboration underscores Luxembourg’s dedication to promoting an environment where research seamlessly transitions into tangible healthcare solutions, driving positive change in the healthcare landscape.

Photo: copyright LIH


Lorem ipsum dolor sit amet, consectetur adipiscing elit duis tincidunt

Lorem ipsum dolor sit amet, consectetur adipiscing elit donec nulla nulla, tincidunt non ex sed, blandit eleifend elit.

Register now!





Stay tuned!

Sign up now and receive the latest news about our ecosystem into your inbox.